Properties
Description
Marizomib, soluble in DMSO, interferes with the proteasome’s ability to degrade proteins, thereby disrupting cellular processes in cancer cells, particularly multiple myeloma.
Molecular Formula
C15H20ClNO4
Solubility
DMSO: 59 mg/mL (188.02 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
Marizomib is used to explore proteasome inhibition, affecting protein homeostasis and offering insight into treating various cancers.
